首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
【2h】

Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.

机译:1-oxa-β-内酰胺(LY127935)和头孢哌酮与其他β-内酰胺类抗生素对厌氧细菌的体外活性比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vitro activity of 1-oxa-beta-lactam (LY127935), cefoperazone (T-1551), cefuroxime, cefsulodin, cefaclor, cefotaxime, and cefoxitin on 85 anaerobic clinical isolates (30 Bacteroides, 30 Clostridium, 25 Peptococcaceae) was simultaneously determined by the agar dilution test in two different media, Brucella Agar (Difco Laboratories) and Wilkins-Chalgren agar. In Wilkins-Chalgren agar, 90% of Bacteroides were inhibited by (micrograms per milliliter): LY127935, 0.5; T-1551, 64; cefoxitin or cefuroxime, 8; cefsulodin or cefotaxime, 32; and cefaclor, 128. All Clostridia were inhibited in Wilkins-Chalgren by (micrograms per milliliter): LY127935, 4; T-1551, 2; cefoxitin, 6; cefuroxime, 0.12; cefsulodin, 0.5; cefaclor, 1; and cefotaxime, 8. All Peptococccaceae were inhibited by T-1551, cefsulodin or cefotaxime at 4 microgram/ml and by cefoxitin or cefuroxime at 1 to 2 microgram/ml. With cefaclor at 8 microgram/ml, 92% of strains were inhibited, and LY127935 at 16 microgram/ml only inhibited 64% of strains. LY127935 was the most active of the antibiotics tested against Bacteroides, showing good activity against Clostridia and poor activity on Peptococcaceae, whereas T-1551 was more active against Peptococccaceae and had similar activity against Clostridia and poor activity on Bacteroides. There are no significant differences between minimal inhibitory concentrations obtained in Brucella Agar and those obtained in Wilkins-Chalgren.
机译:1-oxa-β-内酰胺(LY127935),头孢哌酮(T-1551),头孢呋辛,头孢磺啶,头孢克洛,头孢噻肟和头孢西丁对85种厌氧临床分离株(30种拟杆菌,30种梭菌,25种球菌科)的同时活性。通过琼脂稀释试验在两种不同的培养基,布鲁切拉琼脂(Difco Laboratories)和威尔金斯-夏格伦琼脂中测定。在Wilkins-Chalgren琼脂中,90%的拟杆菌被(微克/毫升)抑制:LY127935,0.5; T-1551,64;头孢西丁或头孢呋辛8头孢磺啶或头孢噻肟,32; (微克/毫升):LY127935,4;和头孢克洛,128。 T-1551,2;头孢西丁6;头孢呋辛0.12;头孢磺啶0.5;头孢克洛1; T-1551,头孢磺啶或头孢噻肟以4微克/毫升和头孢西丁或头孢呋辛以1-2微克/毫升抑制所有肽球菌。头孢克洛浓度为8微克/毫升时,抑制了92%的菌株,而16微克/毫升的LY127935仅抑制了64%的菌株。 LY127935是所测试的抗拟杆菌的活性最高的抗生素,对梭菌具有良好的活性,对肽球菌科的活性较弱,而T-1551对肽球菌的活性更高,对梭菌的活性相似,对拟杆菌的活性较弱。在布鲁氏菌琼脂中获得的最小抑菌浓度与在威尔金斯-查尔格伦制得的最小抑菌浓度之间没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号